JP2008526840A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526840A5
JP2008526840A5 JP2007550328A JP2007550328A JP2008526840A5 JP 2008526840 A5 JP2008526840 A5 JP 2008526840A5 JP 2007550328 A JP2007550328 A JP 2007550328A JP 2007550328 A JP2007550328 A JP 2007550328A JP 2008526840 A5 JP2008526840 A5 JP 2008526840A5
Authority
JP
Japan
Prior art keywords
amino
sulfonyl
carbonyl
ethyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526840A (ja
Filing date
Publication date
Priority claimed from GB0500140A external-priority patent/GB0500140D0/en
Priority claimed from GB0521484A external-priority patent/GB0521484D0/en
Application filed filed Critical
Priority claimed from PCT/SE2006/000010 external-priority patent/WO2006073361A1/en
Publication of JP2008526840A publication Critical patent/JP2008526840A/ja
Publication of JP2008526840A5 publication Critical patent/JP2008526840A5/ja
Pending legal-status Critical Current

Links

JP2007550328A 2005-01-06 2006-01-04 新規化合物 Pending JP2008526840A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0500140A GB0500140D0 (en) 2005-01-06 2005-01-06 Novel compounds
GB0521484A GB0521484D0 (en) 2005-10-21 2005-10-21 Novel compounds
PCT/SE2006/000010 WO2006073361A1 (en) 2005-01-06 2006-01-04 Novel pyridine compounds

Publications (2)

Publication Number Publication Date
JP2008526840A JP2008526840A (ja) 2008-07-24
JP2008526840A5 true JP2008526840A5 (enExample) 2008-12-25

Family

ID=36647772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550328A Pending JP2008526840A (ja) 2005-01-06 2006-01-04 新規化合物

Country Status (15)

Country Link
US (1) US20090227555A2 (enExample)
EP (1) EP1836189A1 (enExample)
JP (1) JP2008526840A (enExample)
KR (1) KR20070107024A (enExample)
AR (1) AR055554A1 (enExample)
AU (1) AU2006204159A1 (enExample)
BR (1) BRPI0606437A (enExample)
CA (1) CA2594255A1 (enExample)
IL (1) IL183961A0 (enExample)
MX (1) MX2007008237A (enExample)
NO (1) NO20073101L (enExample)
RU (1) RU2007129779A (enExample)
TW (1) TW200626593A (enExample)
UY (1) UY29325A1 (enExample)
WO (1) WO2006073361A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008140A1 (en) * 2005-07-13 2007-01-18 Astrazeneca Ab New pyridine analogues
WO2008004944A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab Novel crystalline form ii
CN101506193A (zh) * 2006-07-04 2009-08-12 阿斯利康(瑞典)有限公司 新吡啶类似物
CN101511815A (zh) * 2006-07-04 2009-08-19 阿斯利康(瑞典)有限公司 新型吡啶类似物
WO2008004945A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab Novel crystalline forms i and ii
TW200811133A (en) * 2006-07-04 2008-03-01 Astrazeneca Ab New pyridine analogues III 334
UY30866A1 (es) * 2007-01-12 2008-09-02 Astrazeneca Ab Nuevos compuestos de piridina, composiciones farmacéuticas conteniéndolos y aplicaciones (519)
AR064867A1 (es) * 2007-01-12 2009-04-29 Astrazeneca Ab Analogos de piridina viii 518
UY30867A1 (es) * 2007-01-12 2008-09-02 Astrazeneca Ab Nuevos analogos de piridina vii 543
CA2690243A1 (en) * 2007-06-18 2008-12-24 Sanofi-Aventis Pyrrole derivatives as p2y12 antagonists
WO2009011627A1 (en) * 2007-07-13 2009-01-22 Astrazeneca Ab Pyridine compounds and their use as p2y12 antagonists
AR074628A1 (es) * 2008-07-07 2011-02-02 Astrazeneca Ab Derivados de piridina 2- amino-6-alquil sustituidos utiles como inhibidores de p2y12 308
WO2011002067A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 複素環化合物およびその用途
JP2014051434A (ja) * 2010-12-28 2014-03-20 Dainippon Sumitomo Pharma Co Ltd 二環性ピリミジン誘導体
EP2750676B1 (en) 2011-08-30 2018-01-10 University of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
HK1206716A1 (en) 2012-08-21 2016-01-15 霍夫曼-拉罗奇有限公司 Novel pyridine derivatives
GB201604970D0 (en) 2016-03-23 2016-05-04 Syngenta Participations Ag Improvements in or relating to organic compounds
AU2023388768A1 (en) 2022-12-06 2025-05-01 Idorsia Pharmaceuticals Ltd Crystalline adipic acid salt form of a ccr6 antagonist

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2220055C (en) * 1995-05-08 2001-04-24 Pfizer Inc. Dipeptides which promote release of growth hormone
JP2001526178A (ja) * 1997-08-28 2001-12-18 メルク エンド カムパニー インコーポレーテッド ピロリジン系およびピペリジン系ケモカイン受容体活性調節剤
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
ATE309999T1 (de) * 2000-02-04 2005-12-15 Portola Pharm Inc Blutplättchen-adp-rezeptor-inhibitoren
US6906063B2 (en) * 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7018985B1 (en) * 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
FR2820057A1 (fr) * 2001-01-30 2002-08-02 Ct De Transfert De Technologie Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane
AU2002336462A1 (en) * 2001-09-06 2003-03-24 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
AR037097A1 (es) * 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
GB0312609D0 (en) * 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
US7335648B2 (en) * 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7749981B2 (en) * 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7504497B2 (en) * 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
WO2006012226A2 (en) * 2004-06-24 2006-02-02 Incyte Corporation N-substituted piperidines and their use as pharmaceuticals
CN101506193A (zh) * 2006-07-04 2009-08-12 阿斯利康(瑞典)有限公司 新吡啶类似物
CN101511815A (zh) * 2006-07-04 2009-08-19 阿斯利康(瑞典)有限公司 新型吡啶类似物
JP2009542643A (ja) * 2006-07-04 2009-12-03 アストラゼネカ アクチボラグ 新規ピリジン類似体

Similar Documents

Publication Publication Date Title
JP2008526840A5 (enExample)
RU2007129779A (ru) Новые соединения пиридина
JP2007516173A5 (enExample)
JP6503336B2 (ja) シアノトリアゾール化合物
JP2007531752A5 (enExample)
AU2020202167A1 (en) Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
JP2006500369A5 (enExample)
JP2012526803A5 (enExample)
JP2010513444A5 (enExample)
JP2016135778A (ja) シアノトリアゾール化合物の医薬用途
CA2396824A1 (en) Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
RU2205827C2 (ru) Производное ацилпиперазинилпиримидина, способы его получения, фармацевтическая композиция
JP2010513304A5 (enExample)
JP2007519735A5 (enExample)
JP2010514677A5 (enExample)
MX2012008280A (es) Compuestos y metodos.
JP2016523925A5 (enExample)
AU2005230901A1 (en) Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
JP2007508346A5 (enExample)
HRP20170019T1 (hr) Novi pirol-inhibitori od reduktaze s-nitrozoglutationa kao terapeutska sredstva
RU2004112191A (ru) Лактамсодержащие соединения и их производные в качестве ингибиторов фактора ха
JP2007523905A5 (enExample)
JP2007528887A5 (enExample)
RU2007107349A (ru) Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств
KR20070083939A (ko) 아릴옥시 치환된 벤즈이미다졸 유도체